bpc 157 clinical trials humans systematic review Stable Gastric Pentadecapeptide and Wound Healing Heal or Harm: Body Protective
Description
Unlike native amylin, which has an extremely short half-life of minutes, cagrilintide has been engineered for once-weekly subcutaneous administration through strategic amino acid substitutions and fatty acid acylation
"Deca" means ten
Consequently, the lion's share of BPC-157 research has focused on its potential in these areas
It is not a therapeutic good, is not registered on the ARTG, and has not been assessed by the TGA for safety, quality, or efficacy
